Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Jack Barrington, Zaheer Yousef, Christian Peter Subbe
The number of people using wearable technology such as smartwatches and fitness trackers is increasing. Many of these devices can alert the user to a potential arrhythmia such as atrial fibrillation. We aimed to assess potential changes to cardiology practice resulting from their use. An online questionnaire consisting of 12 questions was created and distributed to all consultant cardiologists in Wales. 25 of 102 participants replied, with 92% of these using consumer wearable technology to diagnose atrial fibrillation either 'often' or 'sometimes'...
March 2024: Future Healthcare Journal
#2
JOURNAL ARTICLE
Sadandaula Rose Muheriwa-Matemba, Amrit Baral, Alireza Abdshah, Bria-Necole Amazing Diggs, Kathryn Sierra Gerber Collazos, Kyana Breche Morris, Sarah Elizabeth Messiah, Denise Christina Vidot
Aim: Knowledge of the cardiovascular and respiratory effects of cannabis use by route of administration is unclear. This evidence is necessary to increase clinical and public health awareness given the recent trend in cannabis legalization, normalization, and surge in the availability and usage of various forms of cannabis products. Methods: Search was conducted in Web of Science, ProQuest, Psych INFO, Scopus, Embase, and Medline databases, and subsequently in the references of retrieved articles. Peer-reviewed articles published between 2009 and 2023, that reported on cardiovascular and respiratory effects of cannabis use by route of administration were included...
April 21, 2024: Substance Use & Misuse
#3
JOURNAL ARTICLE
Andrew Krumerman, Luigi Di Biase, Edward Gerstenfeld, Timm Dickfeld, Nishant Verma, Leonardo Liberman, Richard Amara, Ardit Kacorri, Lori Crosson, Alan Wilk, Kevin J Ferrick
BACKGROUND: Premature ventricular contractions (PVCs) burden is a risk factor for heart failure and cardiovascular death in patients with structural heart disease. Long-term ECG monitoring can have a significant impact on PVC burden evaluation by further defining PVC distribution patterns. OBJECTIVE: This study aimed to ascertain the optimal duration of ECG monitoring to characterize PVC burden and understand clinical characteristics associated with frequent PVCs and NSVT in a large US cohort...
April 17, 2024: Heart Rhythm: the Official Journal of the Heart Rhythm Society
#4
REVIEW
Anastasios Apostolos, Dimitrios Tsiachris, Maria Drakopoulou, Georgios Trantalis, Georgios Oikonomou, Nikolaos Ktenopoulos, Chrysavgi Simopoulou, Odysseas Katsaros, Sotirios Tsalamandris, Constantina Aggeli, Georgios Tsivgoulis, Costas Tsioufis, Konstantinos Toutouzas
This comprehensive review explores the incidence, pathophysiology, and management of atrial fibrillation (AF) following percutaneous closure of patent foramen ovale (PFO). Although AF is considered a common adverse event post PFO closure, its incidence, estimated at <5%, varies based on monitoring methods. The review delves into the challenging task of precisely estimating AF incidence, given subclinical AF and diverse diagnostic approaches. Notably, a temporal pattern emerges, with peak incidence around the 14th day after closure and a subsequent decline after the 45th day, mimicking general population AF trends...
April 19, 2024: Journal of the American Heart Association
#5
JOURNAL ARTICLE
Marco Zuin, Luisa Ojeda-Fernández, Ginevra Torrigiani, Matteo Bertini
BACKGROUND: Data regarding the risk of atrial fibrillation (AF) during the post-acute phase of COVID-19 are lacking. OBJECTIVE: We assess the risk of incident AF in COVID-19 recovered patients by performing a systematic review and meta-analysis of the available data. METHODS: Following the PRIMSA guidelines, we searched Medline and Scopus to locate all articles published up to December 10, 2023, reporting the risk of AF in patients recovered from COVID-19 infection compared to non-infected patients who developed the arrhythmia over the same follow-up period...
April 16, 2024: Heart Rhythm: the Official Journal of the Heart Rhythm Society
#6
REVIEW
Anne-Lotte C J van der Lingen, Tom E Verstraelen, Lieselot van Erven, Joan G Meeder, Dominic A Theuns, Kevin Vernooy, Arthur A M Wilde, Alexander H Maass, Cornelis P Allaart
International guidelines recommend implantation of an implantable cardioverter-defibrillator (ICD) in non-ischaemic cardiomyopathy (NICM) patients with a left ventricular ejection fraction (LVEF) below 35% despite optimal medical therapy and a life expectancy of more than 1 year with good functional status. We propose refinement of these recommendations in patients with NICM, with careful consideration of additional risk parameters for both arrhythmic and non-arrhythmic death. These additional parameters include late gadolinium enhancement on cardiac magnetic resonance imaging and genetic testing for high-risk genetic variants to further assess arrhythmic risk, and age, comorbidities and sex for assessment of non-arrhythmic mortality risk...
April 18, 2024: Netherlands Heart Journal
#7
EDITORIAL
N A Mark Estes
No abstract text is available yet for this article.
April 18, 2024: Journal of Cardiovascular Electrophysiology
#8
REVIEW
Béla Eckhardt, Andrea Kaifie
BACKGROUND: Although several studies analyzed the impact of e-waste recycling on human health, most publications did not differ between e-waste workers and bystanders, such as residents. This could lead to an underestimation of health effects in workers. In addition, frequently reported surrogate findings do not properly reflect clinical significant health outcomes. The aim of this review was to analyze the direct health effects of informal e-waste recycling in informal e-waste workers...
April 15, 2024: Journal of Occupational Medicine and Toxicology
#9
REVIEW
Meissa Hamza, Romain Carron, Maxine Dibué, Alessandro Moiraghi, Sami Barrit, Cristina Filipescu, Elisabeth Landré, Martine Gavaret, Philippe Domenech, Johan Pallud, Marc Zanello
BACKGROUND: Right-sided vagus nerve stimulation (RS-VNS) is indicated when the procedure was deemed not technically feasible or too risky on the indicated left side. OBJECTIVE: The present study aims to systematically review the literature on RS-VNS, assessing its effectiveness and safety. METHODS: A systematic review following PRISMA guidelines was conducted: Pubmed/MEDLINE, The Cochrane Library, Scopus, Embase and Web of science databases were searched from inception to August 13th,2023...
February 19, 2024: Seizure: the Journal of the British Epilepsy Association
#10
JOURNAL ARTICLE
Damian Kaufmann, Tomasz Królak, Alicja Dąbrowska-Kugacka, Agnieszka Kapłon-Cieślicka, Monika Gawałko, Monika Budnik, Beata Uziębło-Życzkowska, Paweł Krzesiński, Katarzyna Starzyk, Beata Wożakowska-Kapłon, Maciej Wójcik, Robert Błaszczyk, Jarosław Hiczkiewicz, Jan Budzianowski, Katarzyna Mizia-Stec, Maciej T Wybraniec, Katarzyna Kosmalska, Marcin Fijałkowski, Anna Szymańska, Mirosław Dłużniewski, Maciej Haberka, Michał Kucio, Błażej Michalski, Karolina Kupczyńska, Anna Tomaszuk-Kazberuk, Katarzyna Wilk-Śledziewska, Renata Wachnicka-Truty, Marek Koziński, Paweł Burchardt, Ludmiła Daniłowicz-Szymanowicz
BACKGROUND: According to the present guidelines, transesophageal echocardiography (TEE) before scheduled catheter ablation (CA) for atrial arrhythmias (atrial fibrillation [AF] or atrial flutter [AFL]) is not deemed obligatory for optimally anticoagulated patients. However, daily clinical practice significantly differs from the recommendations. AIMS: That study aimed to identify transthoracic echocardiographic parameters that could be useful in revealing patients without left atrial thrombus (LAT), thereby contributing to avoiding unnecessary TEE before scheduled CA...
April 12, 2024: Kardiologia Polska
#11
JOURNAL ARTICLE
Mitchell I Cohen, Melany B Atkins, Christopher P Jordan
PURPOSE OF REVIEW: The aim of this study is to provide an update on mitral valve prolapse (MVP) and mitral annular disjunction (MAD) and who may be at risk for ventricular arrhythmias and sudden cardiac death. RECENT FINDINGS: MVP is generally considered a benign condition. However, a small subset of patients may be at risk for life-threatening ventricular arrhythmias. Among the risk factors identified in adults include patients with bileaflet mitral valves, myxomatous changes, myocardial fibrosis, and the presence of MAD...
April 9, 2024: Current Opinion in Cardiology
#12
JOURNAL ARTICLE
Karen Abboud, Godsfavour Umoru, Barry Trachtenberg, Veronica Ajewole
BACKGROUND: Oral cancer therapy-related cardiovascular (CV) toxicity has a wide variety of presentations including arrhythmia, cardiomyopathy, and myocardial infarction, but clinical evidence related to its management is limited. The purpose of this IRB-approved, single-center, retrospective, cohort study was to characterize cardio-oncologic interventions for CV adverse events related to oral oncolytics. METHODS: The cohort included 67 patients who were admitted to a multi-hospital health system between June 1, 2016 and July 31, 2021, had at least one medical record order of oral oncolytics considered to have cardiotoxic potential, and had an ICD10 code for a cardiotoxic event added to their electronic medical records after initiation of oral oncolytics...
April 9, 2024: Cardio-Oncology
#13
REVIEW
Paolo Compagnucci, Adelina Selimi, Laura Cipolletta, Giovanni Volpato, Alessio Gasperetti, Yari Valeri, Quintino Parisi, Antonio Curcio, Andrea Natale, Antonio Dello Russo, Michela Casella
Although mitral valve prolapse (MVP) is the most prevalent valvular abnormality in Western countries and generally carries a good prognosis, a small subset of patients is exposed to a significant risk of malignant ventricular arrhythmias (VAs) and sudden cardiac death (SCD), the so-called arrhythmic MVP (AMVP) syndrome. Recent work has emphasized phenotypical risk features of severe AMVP and clarified its pathophysiology. However, the appropriate assessment and risk stratification of patients with suspected AMVP remains a clinical conundrum, with the possibility of both overestimating and underestimating the risk of malignant VAs, with the inappropriate use of advanced imaging and invasive electrophysiology study on one hand, and the catastrophic occurrence of SCD on the other...
February 27, 2024: Journal of Clinical Medicine
#14
REVIEW
Wael Zaher, Domenico Giovanni Della Rocca, Luigi Pannone, Serge Boveda, Carlo de Asmundis, Gian-Battista Chierchia, Antonio Sorgente
Sudden cardiac death (SCD) accounts for a substantial proportion of mortality in heart failure with reduced ejection fraction (HFrEF), frequently triggered by ventricular arrhythmias (VA). This review aims to analyze the pathophysiological mechanisms underlying VA and SCD in HFrEF and evaluate the effectiveness of guideline-directed medical therapy (GDMT) in reducing SCD. Beta-blockers, angiotensin receptor-neprilysin inhibitors, and mineralocorticoid receptor antagonists have shown significant efficacy in reducing SCD risk...
February 26, 2024: Journal of Clinical Medicine
#15
JOURNAL ARTICLE
Dominik Linz, Jason G Andrade, Elena Arbelo, Giuseppe Boriani, Guenter Breithardt, A John Camm, Valeria Caso, Jens Cosedis Nielsen, Mirko De Melis, Tom De Potter, Wolfgang Dichtl, Søren Zoega Diederichsen, Dobromir Dobrev, Nicolas Doll, David Duncker, Elke Dworatzek, Lars Eckardt, Christoph Eisert, Larissa Fabritz, Michal Farkowski, David Filgueiras-Rama, Andreas Goette, Eduard Guasch, Guido Hack, Stéphane Hatem, Karl Georg Haeusler, Jeff S Healey, Hein Heidbuechel, Ziad Hijazi, Lucas H Hofmeister, Leif Hove-Madsen, Thomas Huebner, Stefan Kääb, Dipak Kotecha, Katarzyna Malaczynska-Rajpold, José Luis Merino, Andreas Metzner, Lluís Mont, Ghulam Andre Ng, Michael Oeff, Abdul Shokor Parwani, Helmut Puererfellner, Ursula Ravens, Michiel Rienstra, Prashanthan Sanders, Daniel Scherr, Renate Schnabel, Ulrich Schotten, Christian Sohns, Gerhard Steinbeck, Daniel Steven, Tobias Toennis, Stylianos Tzeis, Isabelle C van Gelder, Roderick H van Leerdam, Kevin Vernooy, Manish Wadhwa, Reza Wakili, Stephan Willems, Henning Witt, Stef Zeemering, Paulus Kirchhof
AIMS: Recent trial data demonstrate beneficial effects of active rhythm management in patients with atrial fibrillation (AF) and support the concept that a low arrhythmia burden is associated with a low risk of AF-related complications. The aim of this document is to summarize the key outcomes of the 9th AFNET/EHRA Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA). METHODS AND RESULTS: Eighty-three international experts met in Münster for 2 days in September 2023...
March 30, 2024: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
#16
Bharat K Kantharia, Zaw Win Tun, Arti N Shah
Pulmonary vein (PV) isolation (PVI) ablation as the first-line therapy for atrial fibrillation (AF) and repeat PVIs for patients who had symptomatic improvement with the index PVI but who develop AF recurrence are directed by practice guidelines. How many catheter ablation (CA) procedures constitute the definition of "multiple" ablations is not known. Whether atrial tachyarrhythmias (AF, atrial tachycardia [AT], atrial flutter [AFL]) that occur post-ablation are due entirely to the proarrhythmic effects of CA or a continuum of the arrhythmia spectrum from the underlying atriopathy is debatable...
March 2024: Journal of Innovations in Cardiac Rhythm Management
#17
JOURNAL ARTICLE
Sarah E Haskell, Derek Hoyme, M Bridget Zimmerman, Ron Reeder, Saket Girotra, Tia T Raymond, Ricardo A Samson, Marc Berg, Robert A Berg, Vinay Nadkarni, Dianne L Atkins
BACKGROUND: Annually 15,200 children suffer an in-hospital cardiac arrest (IHCA) in the US. Ventricular fibrillation or pulseless ventricular tachycardia (VF/pVT) is the initial rhythm in 10-15% of these arrests. We sought to evaluate the association of number of shocks and early dose escalation with survival for initial VF/pVT in pediatric IHCA. METHODS: Using 2000-2020 data from the American Heart Association's (AHA) Get with the Guidelines® -Resuscitation (GWTG-R) registry, we identified children > 48 hours of life and ≤ 18 years who had an IHCA from initial VF/pVT and received defibrillation...
April 4, 2024: Resuscitation
#18
JOURNAL ARTICLE
Emanuele Monda, Athanasios Bakalakos, Douglas Cannie, Constantinos O'Mahony, Petros Syrris, Juan Pablo Kaski, Giuseppe Limongelli, Perry Mark Elliott
BACKGROUND: Acute myocarditis is an inflammatory condition that may precede the development of dilated or arrhythmogenic cardiomyopathy. OBJECTIVES: The aim of this study was to investigate the reported prevalence of pathogenic or likely pathogenic (P/LP) variants in cardiomyopathy-associated genes in patients with acute myocarditis. METHODS: For this systematic review and meta-analysis, the PubMed and Embase databases were searched on March 4, 2023...
March 25, 2024: JACC. Heart Failure
#19
REVIEW
Wenjing Zhu, Hui Yuan, Jianli Lv
BACKGROUND: Premature ventricular contractions (PVCs) are relatively common arrhythmias in the pediatric population, with implications that range from benign to potentially life-threatening. The management of PVCs in children poses unique challenges, and recent advancements in diagnostic and therapeutic options call for a comprehensive review of current practices. METHODS: This review synthesizes the latest literature on pediatric PVCs, focusing on publications from the past decade...
2024: Frontiers in Pediatrics
#20
JOURNAL ARTICLE
Hei-To Leung, Sit-Yee Kwok, Ka-Yee Kwong, Fong-Ying Shih, Sabrina Tsao, Brian Hon-Yin Chung
Congenital long QT syndrome (LQTS) is an inherited arrhythmia syndrome associated with sudden cardiac death. Accurate interpretation and classification of genetic variants in LQTS patients are crucial for effective management. All patients with LQTS with a positive genetic test over the past 18 years (2002-2020) in our single tertiary pediatric cardiac center were identified. Reevaluation of the reported variants in LQTS genes was conducted using the American College of Genetics and Genomics (ACMG) guideline after refinement by the US ClinGen SVI working group and guideline by Walsh et al...
April 2, 2024: Pediatric Cardiology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
